{"result": "(\"entity\"<|>CLIN NUTR<|>ORGANIZATION<|>Clin Nutr is a journal that publishes research and position papers related to clinical nutrition and metabolism.)\n##\n(\"entity\"<|>DE LUIS DA<|>PERSON<|>De Luis DA is an editor involved in the publication of works related to clinical nutrition and metabolism.)\n##\n(\"entity\"<|>TOLEDO<|>GEO<|>Toledo is a city in Spain where the 3rd edition of the book on diet therapy was published.)\n##\n(\"entity\"<|>AULA MÉDICA<|>ORGANIZATION<|>Aula Médica is a publishing house that published the book on diet therapy referenced in the text.)\n##\n(\"entity\"<|>NUTRICIÓN CLÍNICA Y METABOLISMO<|>EVENT<|>Nutrición clínica y metabolismo refers to the field of study and practice focused on the nutritional needs and metabolic processes of patients.)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>CLIN NUTR<|>The European Society for Clinical Nutrition and Metabolism contributes to the research published in Clin Nutr<|>7)\n##\n(\"relationship\"<|>DE LUIS DA<|>AULA MÉDICA<|>De Luis DA is an editor for works published by Aula Médica, particularly in the field of clinical nutrition<|>6)\n##\n(\"relationship\"<|>TOLEDO<|>AULA MÉDICA<|>Aula Médica published a book on diet therapy in Toledo<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN CLÍNICA Y METABOLISMO<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>The European Society for Clinical Nutrition and Metabolism focuses on the field of clinical nutrition and metabolism<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: rición. 2016. Disponible en: https://manual.seen.es.\n         • Klek S, Forbes A, Gabe S, Holst M, Wanten G, Irtun Ø, et al. Management of acute intestinal failure: A position paper from the\n           European Society for Clinical Nutrition and Metabolism (ESPEN) Special Interest Group. Clin Nutr. 2016;35(6):1209-18.\n         • López Gómez JJ, Torres Torres B, Gómez Hoyos E, Ortolá Buigues A, de Luis Román DA. Nutrición enteral: concepto, indicación,\n           fórmulas, seguimiento y complicaciones. En: de Luis DA, Bellido Guerrero D, García Luna PP, Olveira Fuster G, eds. Dietoterapia,        Señale la respuesta correcta en relación con las fórmulas oligomonoméricas\n           nutrición clínica y metabolismo. 3.ª ed. Toledo: Aula Médica; 2017. p. 733-52.                                                      23  de nutrición enteral:\n         Una fórmula de nutrición enteral (indique la opción correcta):                                                                            A.    Son aquellas en las que se usan ácidos grasos libres como fuente de aporte lipídico.\n     22                                                                                                                                            B.    Los hidratos de carbono que llevan suelen estar en forma de dextrinomaltosa, aunque\n         A. Se considera isotónica cuando su osmolalidad se encuentra en torno a 350 mOsm/kg.                                                            también se usan oligosacáridos de glucosa y disacáridos como fructosa y maltosa.\n         B. Se denomina hipercalórica cuando aporta más de 1,1 kcal/ml.                                                                            C.    La osmolalidad de este grupo de fórmulas es habitualmente menor que la de las\n         C. Tiene como fuente de proteínas más habitual la caseína, a la que se añaden                                                                   fórmulas poliméricas.\n             ocasionalmente proteínas de soja y lactoalbúmina.                                                                                     D.    Los lípidos constituyen habitualmente la principal fuente calórica, con porcentajes\n         D.  Todas las opciones son correctas.                                                                                                           superiores al 40% del total del contenido calórico.\n\n\n\n         COMENTARIO                                                                                                                                COMENTARIO\n         Las fórmulas de nutrición enteral (NE) son productos constituidos por macro- y micronu-                                                   Las fórmulas oligomonoméricas son productos de nutrición enteral en las que las proteínas\n         trientes que se utilizan para alimentar a un paciente que no es capaz de hacerlo de forma                                                 se encuentran hidrolizadas en pequeños péptidos a aminoácidos libres. Se clasifican según\n         natural. Son nutricionalmente completas.                                                                                                  el algoritmo de la figura 1.\n         La osmolalidad se define como el número de partículas osmóticamente activas por kilogra-\n         mo de disolvente, y en las fórmulas de nutrición enteral viene determinada principalmente\n\n\n\n216                                                                                                                                                                                                                                                                              217\n---\n                                                                                                                                                                                                                                                 NUTRICIÓN                            4\n\n\n\n                                                                                                                                                            COMENTARIO\n                                                          Fórmulas oligomonoméricas                                                                         El soporte nutricional artificial está indicado en pacientes con pancreatitis aguda que cum-\n                                                                                                                                                            plen criterios de gravedad. La vía de elección es la enteral siempre que sea posible, mediante\n                                                                                                                                                            la colocación de una sonda nasoentérica. Respecto a la nutrición parenteral, el uso de nutri-\n                                  Fórmulas peptídicas                                     Fórmulas elementales                                              ción enteral se asocia a una disminución más rápida del dolor, de los niveles de amilasa y de\n                                                                                                                                                            los marcadores inflamatorios, y a una recuperación más temprana de la ingesta oral. La nu-\n                                                                                                                                                            trición parenteral se emplea en aquellos casos de pancreatitis grave en los que no es posible\n                      Normoproteicas                Hiperproteicas                                                                                          obtener un acceso enteral, o la nutrición enteral no se tolera en cantidad suficiente como para\n                                                                                                                                                            cubrir los requerimientos nutricionales.\n                                                                                                                                                            El metabolismo lipídico se puede ver alterado en las pancreatitis agudas, por lo que la admi-\n               Figura 1. Clasificación de las fórmulas oligomonoméricas.                                                                                    nistración de emulsiones lipídicas por vía parenteral es controvertida. Se deben monitorizar\n               En cuanto al resto de su composición, sus características son:                                                                               los niveles de triglicéridos y suspender la administración de estas si se superan los 400 mg/dl.\n               •  Los hidratos de carbono se aportan en forma de dextrinomaltosa, aunque también se uti-                                                    En el 90% de los casos de pancreatitis grave se puede encontrar hiperglucemia como con-\n                  lizan oligosacáridos de glucosa y disacáridos como fructosa y maltosa. Son la principal                                                   secuencia del incremento de\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>ORGANIZATION<|>The European Society for Clinical Nutrition and Metabolism (ESPEN) is an organization focused on clinical nutrition and metabolism, providing guidelines and position papers for healthcare professionals.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>EVENT<|>Nutrición enteral refers to the process of providing nutrition to patients who cannot eat naturally, using specially formulated products.)\n##\n(\"entity\"<|>PANCREATITIS AGUDA<|>EVENT<|>Pancreatitis aguda is a medical condition characterized by the sudden inflammation of the pancreas, often requiring nutritional support.)\n##\n(\"entity\"<|>SONDA NASOENTÉRICA<|>EVENT<|>Sonda nasoentérica is a medical device used for enteral feeding, allowing nutrition to be delivered directly to the stomach.)\n##\n(\"entity\"<|>FÓRMULAS OLIGOMONOMÉRICAS<|>EVENT<|>Fórmulas oligomonoméricas are specialized enteral nutrition products containing hydrolyzed proteins, designed for patients with specific dietary needs.)\n##\n(\"entity\"<|>FÓRMULAS PEPTÍDICAS<|>EVENT<|>Fórmulas peptídicas are enteral nutrition products that provide proteins in the form of peptides, suitable for patients with certain digestive conditions.)\n##\n(\"entity\"<|>FÓRMULAS ELEMENTALES<|>EVENT<|>Fórmulas elementales are enteral nutrition products that contain nutrients in their simplest form, often used for patients with severe malabsorption issues.)\n##\n(\"relationship\"<|>EUROPEAN SOCIETY FOR CLINICAL NUTRITION AND METABOLISM<|>NUTRICIÓN ENTERAL<|>The European Society for Clinical Nutrition and Metabolism provides guidelines and position papers on enteral nutrition practices<|>8)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>PANCREATITIS AGUDA<|>Enteral nutrition is indicated for patients with acute pancreatitis to support recovery<|>7)\n##\n(\"relationship\"<|>PANCREATITIS AGUDA<|>SONDA NASOENTÉRICA<|>A nasoenteric tube is often used for enteral feeding in patients with acute pancreatitis<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>FÓRMULAS OLIGOMONOMÉRICAS<|>Oligomonic formulas are a type of enteral nutrition specifically designed for patients with certain dietary restrictions<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>FÓRMULAS PEPTÍDICAS<|>Peptide formulas are used in enteral nutrition to provide easily digestible proteins<|>6)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>FÓRMULAS ELEMENTALES<|>Elemental formulas are a category of enteral nutrition products used for patients with severe malabsorption<|>6)\n<|COMPLETE|>"}]}